81_FR_7575 81 FR 7546 - Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; Request for Samples and Protocols

81 FR 7546 - Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; Request for Samples and Protocols

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration

Federal Register Volume 81, Issue 29 (February 12, 2016)

Page Range7546-7546
FR Document2016-02882

The Food and Drug Administration (FDA) is announcing that a collection of information entitled ``Request for Samples and Protocols'' has been approved by the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995.

Federal Register, Volume 81 Issue 29 (Friday, February 12, 2016)
[Federal Register Volume 81, Number 29 (Friday, February 12, 2016)]
[Notices]
[Page 7546]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2016-02882]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2012-N-0114]


Agency Information Collection Activities; Announcement of Office 
of Management and Budget Approval; Request for Samples and Protocols

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is announcing that a 
collection of information entitled ``Request for Samples and 
Protocols'' has been approved by the Office of Management and Budget 
(OMB) under the Paperwork Reduction Act of 1995.

FOR FURTHER INFORMATION CONTACT: FDA PRA Staff, Office of Operations, 
Food and Drug Administration, 8455 Colesville Rd., COLE-14526, Silver 
Spring, MD 20993-0002, [email protected].

SUPPLEMENTARY INFORMATION: On September 24, 2015, the Agency submitted 
a proposed collection of information entitled ``Request for Samples and 
Protocols'' to OMB for review and clearance under 44 U.S.C. 3507. An 
Agency may not conduct or sponsor, and a person is not required to 
respond to, a collection of information unless it displays a currently 
valid OMB control number. OMB has now approved the information 
collection and has assigned OMB control number 0910-0206. The approval 
expires on December 31, 2018. A copy of the supporting statement for 
this information collection is available on the Internet at http://www.reginfo.gov/public/do/PRAMain.

    Dated: February 8, 2016.
Leslie Kux,
Associate Commissioner for Policy.
[FR Doc. 2016-02882 Filed 2-11-16; 8:45 am]
 BILLING CODE 4164-01-P



                                                     7546                           Federal Register / Vol. 81, No. 29 / Friday, February 12, 2016 / Notices

                                                     forms that are equivalent. The State                     documentation requirements of a                       requirement of the standard, and (3)
                                                     program maintains the documents and                      standard, it develops a strategic plan                projected completion dates for each
                                                     verifies records required for each                       which includes the following: (1) The                 task.
                                                     standard. The information contained in                   individual element of documentation                     FDA estimates the burden of this
                                                     the documents must be current and fit-                   requirement of the standard that was not              collection of information as follows:
                                                     for-use. If the State program fails to meet              met, (2) improvements needed to meet
                                                     all program elements and                                 the program element or documentation

                                                                                                     TABLE 1—ESTIMATED ANNUAL REPORTING BURDEN 1
                                                                                                                                                 Number of                              Average
                                                                                                                              Number of           responses        Total annual
                                                                                Respondent                                                                                            burden per   Total hours
                                                                                                                             respondents             per            responses          response
                                                                                                                                                 respondent

                                                     State Departments of Agriculture or Health ........................          42                   1                42               750         31,500
                                                        1 There   are no capital costs or operating and maintenance costs associated with this collection of information.


                                                       The burden has been calculated as                      information entitled ‘‘Request for                       Location: FDA White Oak Campus,
                                                     750 hours per respondent. This burden                    Samples and Protocols’’ to OMB for                    10903 New Hampshire Ave., Bldg. 31
                                                     was determined by capturing the                          review and clearance under 44 U.S.C.                  Conference Center, the Great Room (Rm.
                                                     average amount of time for each                          3507. An Agency may not conduct or                    1503), Silver Spring, MD 20993–0002.
                                                     respondent to assess the current state of                sponsor, and a person is not required to              Answers to commonly asked questions
                                                     the program and work toward                              respond to, a collection of information               including information regarding special
                                                     implementation of each of the 10                         unless it displays a currently valid OMB              accommodations due to a disability,
                                                     standards contained in MFRPS. The                        control number. OMB has now                           visitor parking, and transportation may
                                                     hours per respondent will change as                      approved the information collection and               be accessed at: http://www.fda.gov/
                                                     accounted for in the continuing                          has assigned OMB control number                       AdvisoryCommittees/
                                                     improvement and self-sufficiency of the                  0910–0206. The approval expires on                    AboutAdvisoryCommittees/
                                                     program.                                                 December 31, 2018. A copy of the                      ucm408555.htm.
                                                       Dated: February 8, 2016.                               supporting statement for this                            Contact Person: Cindy Hong, Center
                                                     Leslie Kux,                                              information collection is available on                for Drug Evaluation and Research, Food
                                                     Associate Commissioner for Policy.
                                                                                                              the Internet at http://www.reginfo.gov/               and Drug Administration, 10903 New
                                                                                                              public/do/PRAMain.                                    Hampshire Ave., Bldg. 31, Rm. 2417,
                                                     [FR Doc. 2016–02888 Filed 2–11–16; 8:45 am]
                                                                                                                Dated: February 8, 2016.                            Silver Spring, MD 20993–0002, 301–
                                                     BILLING CODE 4164–01–P
                                                                                                              Leslie Kux,                                           796–9001, FAX: 301–847–8533,
                                                                                                              Associate Commissioner for Policy.
                                                                                                                                                                    GIDAC@fda.hhs.gov, or FDA Advisory
                                                     DEPARTMENT OF HEALTH AND                                                                                       Committee Information Line, 1–800–
                                                                                                              [FR Doc. 2016–02882 Filed 2–11–16; 8:45 am]
                                                     HUMAN SERVICES                                                                                                 741–8138 (301–443–0572 in the
                                                                                                              BILLING CODE 4164–01–P
                                                                                                                                                                    Washington, DC area). A notice in the
                                                     Food and Drug Administration                                                                                   Federal Register about last minute
                                                                                                                                                                    modifications that impact a previously
                                                     [Docket No. FDA–2012–N–0114]                             DEPARTMENT OF HEALTH AND
                                                                                                                                                                    announced advisory committee meeting
                                                                                                              HUMAN SERVICES
                                                     Agency Information Collection                                                                                  cannot always be published quickly
                                                     Activities; Announcement of Office of                    Food and Drug Administration                          enough to provide timely notice.
                                                     Management and Budget Approval;                                                                                Therefore, you should always check the
                                                                                                              [Docket No. FDA–2016–N–0001]                          Agency’s Web site at http://
                                                     Request for Samples and Protocols
                                                                                                                                                                    www.fda.gov/AdvisoryCommittees/
                                                     AGENCY:      Food and Drug Administration,               Gastrointestinal Drugs Advisory                       default.htm and scroll down to the
                                                     HHS.                                                     Committee; Notice of Meeting                          appropriate advisory committee meeting
                                                     ACTION:   Notice.                                        AGENCY:      Food and Drug Administration,            link, or call the advisory committee
                                                                                                              HHS.                                                  information line to learn about possible
                                                     SUMMARY:   The Food and Drug                                                                                   modifications before coming to the
                                                     Administration (FDA) is announcing                       ACTION:   Notice.
                                                                                                                                                                    meeting.
                                                     that a collection of information entitled                  This notice announces a forthcoming                    Agenda: The committee will discuss
                                                     ‘‘Request for Samples and Protocols’’                    meeting of a public advisory committee                new drug application (NDA) 207999,
                                                     has been approved by the Office of                       of the Food and Drug Administration                   obeticholic acid oral tablets, submitted
                                                     Management and Budget (OMB) under                        (FDA). The meeting will be open to the                by Intercept Pharmaceuticals, Inc.,
                                                     the Paperwork Reduction Act of 1995.                     public.                                               proposed for the treatment of primary
                                                     FOR FURTHER INFORMATION CONTACT: FDA
asabaliauskas on DSK9F6TC42PROD with NOTICES2




                                                                                                                Name of Committee: Gastrointestinal                 biliary cirrhosis in combination with
                                                     PRA Staff, Office of Operations, Food                    Drugs Advisory Committee.                             ursodeoxycholic acid (UDCA) in adults
                                                     and Drug Administration, 8455                              General Function of the Committee:                  with an inadequate response to UDCA
                                                     Colesville Rd., COLE–14526, Silver                       To provide advice and                                 or as monotherapy in adults unable to
                                                     Spring, MD 20993–0002, PRAStaff@                         recommendations to the Agency on                      tolerate UDCA.
                                                     fda.hhs.gov.                                             FDA’s regulatory issues.                                 FDA intends to make background
                                                     SUPPLEMENTARY INFORMATION: On                              Date and Time: The meeting will be                  material available to the public no later
                                                     September 24, 2015, the Agency                           held on April 7, 2016, from 8 a.m. to 5               than 2 business days before the meeting.
                                                     submitted a proposed collection of                       p.m.                                                  If FDA is unable to post the background


                                                VerDate Sep<11>2014    17:38 Feb 11, 2016   Jkt 238001   PO 00000   Frm 00050   Fmt 4703   Sfmt 4703   E:\FR\FM\12FEN1.SGM   12FEN1



Document Created: 2016-02-12 01:24:18
Document Modified: 2016-02-12 01:24:18
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
ActionNotice.
ContactFDA PRA Staff, Office of Operations, Food and Drug Administration, 8455 Colesville Rd., COLE-14526, Silver Spring, MD 20993-0002, [email protected]
FR Citation81 FR 7546 

2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR